Pharmacology of the human red cell voltage-dependent cation channel: Part I. Activation by clotrimazole and analogues

The activation and pharmacological modulation of the nonselective voltage-dependent cation (NSVDC) channel from human erythrocytes were studied. Basic channel activation was achieved by suspending red cells in a low Cl− Ringer (2 mM), where a positive membrane potential (Vm = ECl) immediately developed. Voltage- and time-dependent activation of the NSVDC channel occurred, reaching a cation conductance (g+) of 1.5–2.0 μS cm−2. In the presence of the classical Gárdos channel blocker clotrimazole (0–50 μM), activation occurred faster, and g+ saturated dose-dependently (EC50 = 14 μM) at a value of about 4 μS cm−2. The clotrimazole analogues TRAM-34, econazole, and miconazole also stimulated the channel, whereas the chemically more distant Gárdos channel inhibitors nitrendipine and cetiedil had no effects. Although the potency for modulation of the NSVDC channel is much lower than the IC50 value for Gárdos channel inhibition, clotrimazole (and its analogues) constitutes the first chemical class of positive modulators of the NSVDC channel. This may be an important pharmacological “fingerprint” in the identification of the cloned equivalent of the erythrocyte channel.